Aquamarine Financial (Cayman) Ltd: ORAMED PHARMACEUTICALS INC (ORMP): Quarterly 13F Position History
As of Q2 2026, Aquamarine Financial (Cayman) Ltd reported 2,512,175 shares of ORAMED PHARMACEUTICALS INC (ORMP), worth $12.1M and representing 0.7% of its 13F equity book. Quarter-over-quarter share count change: + 399,863 (+18.9%) . The position first appeared in Q3 2025 and has been disclosed across 4 13F-HR filings in Pactolio's tracked window.
- 2,512,175Shares Held (Latest Filing)
- $12.1MReported Market Value (Latest Filing)
- 0.7%Portfolio Weight (% of 13F Equity Book)
- +399,863Quarter-over-Quarter Share Change
- +$4.9MQuarter-over-Quarter Value Change
- 2,512,175Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 4 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,512,175 | +399,863 | +18.9% | $12.1M | 0.7% | $4.8 |
| Q1 2026 | 2,112,312 | +139,255 | +7.1% | $7.2M | 0.5% | $3.4 |
| Q4 2025 | 1,973,057 | 0 | – | $5.6M | 0.5% | $2.9 |
| Q3 2025 | 1,973,057 | – | – | $5.2M | 0.5% | $2.6 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Aquamarine Financial (Cayman) Ltd first disclose a ORMP position in 13F-HR filings?
Aquamarine Financial (Cayman) Ltd first reported ORAMED PHARMACEUTICALS INC (ORMP) on its 13F-HR filing for the period ending 2025-09-30 (Q3 2025). The position has appeared on 4 reported quarters within Pactolio's tracked window.
What was Aquamarine Financial (Cayman) Ltd's most recent quarter-over-quarter share-count change in ORMP?
Between Q1 2026 and Q2 2026, Aquamarine Financial (Cayman) Ltd added 399,863 shares of ORMP (+18.9%), bringing the total reported position to 2,512,175 shares at a market value of $12.1M.
Does the implied price-per-share represent Aquamarine Financial (Cayman) Ltd's cost basis in ORMP?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.